Neuromyelitis Optica
Symptoms, Doctors, Treatments, Advances & More

Learn About Neuromyelitis Optica

What is the definition of Neuromyelitis Optica?

Neuromyelitis optica is an autoimmune disorder that affects the nerves of the eyes and the central nervous system, which includes the brain and spinal cord. Autoimmune disorders occur when the immune system malfunctions and attacks the body's own tissues and organs. In neuromyelitis optica, the autoimmune attack causes inflammation of the nerves, and the resulting damage leads to the signs and symptoms of the condition.

What are the causes of Neuromyelitis Optica?

No genes associated with neuromyelitis optica have been identified. However, a small percentage of people with this condition have a family member who is also affected, which indicates that there may be one or more genetic changes that increase susceptibility. It is thought that the inheritance of this condition is complex and that many environmental and genetic factors are involved in the development of the condition.

How prevalent is Neuromyelitis Optica?

Neuromyelitis optica affects approximately 1 to 2 per 100,000 people worldwide. Women are affected by this condition more frequently than men.

Is Neuromyelitis Optica an inherited disorder?

Neuromyelitis optica is usually not inherited. Rarely, this condition is passed through generations in families, but the inheritance pattern is unknown.

Who are the top Neuromyelitis Optica Local Doctors?
Elite in Neuromyelitis Optica
Elite in Neuromyelitis Optica
Referral may be required

Johns Hopkins Outpatient Center

Baltimore, MD 
Languages Spoken:
English, Greek
Accepting New Patients
Offers Telehealth

Elias Sotirchos is a Neurologist practicing medicine in Baltimore, Maryland. Dr. Sotirchos is rated as an Elite provider by MediFind in the treatment of Neuromyelitis Optica. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Optic Neuritis, Multiple Sclerosis (MS), Neuromyelitis Optica, and Transverse Myelitis. Dr. Sotirchos is board certified in American Board Of Psychiatry And Neurology. Dr. Sotirchos is currently accepting new patients.

Distinguished in Neuromyelitis Optica
Distinguished in Neuromyelitis Optica
Referral may be required
1600 East Jefferson Street, A Level, 
Seattle, WA 
Languages Spoken:
English, Croatian, Spanish
Accepting New Patients
Offers Telehealth

Pavle Repovic is a Neurologist practicing medicine in Seattle, Washington. Dr. Repovic is rated as a Distinguished provider by MediFind in the treatment of Neuromyelitis Optica. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Neuromyelitis Optica, and Optic Neuritis. Dr. Repovic is board certified in American Board Of Psychiatry And Neurology. Dr. Repovic is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Neuromyelitis Optica
Elite in Neuromyelitis Optica
Referral may be required
Koriyama, JP 

Kazuo Fujihara practices practicing medicine in Koriyama, Japan. Mr. Fujihara is rated as an Elite expert by MediFind in the treatment of Neuromyelitis Optica. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Transverse Myelitis, Neuromyelitis Optica, Optic Neuritis, Myelitis, and Thymectomy.

What are the latest Neuromyelitis Optica Clinical Trials?
An Observational Pregnancy Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® (Inebilizumab-cdon) During Pregnancy

Summary: This is an observational study to monitor female participants exposed to UPLIZNA during pregnancy. This study requires voluntary reporting of pregnancies in female participants with NMOSD exposed to UPLIZNA during pregnancy or within 6 months preceding conception. Pregnancy-related data, potential confounding factors and information related to pregnancy outcome will be collected. The schedule of o...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Real-World Effectiveness and Safety of Satralizumab in the Early Treatment of Attacks in Neuromyelitis Optica Spectrum Disorder: A Multicenter Prospective Cohort Study

Summary: This study is a multicenter, prospective cohort study designed to enroll 50 NMOSD patients who receive Satralizumab treatment during the early phase of an NMOSD attack. Follow-up visits will be conducted at baseline, 3 months, and 6 months to record and assess EDSS scores, modified Rankin Scale (mRS) scores, EQ-5D scores, Activities of Daily Living (ADL) scores, relapse events, safety data, and ex...

Who are the sources who wrote this article ?

Published Date: March 01, 2015
Published By: National Institutes of Health